alveolar epithelial cell
[용어속성] Cell
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
Article
[키워드] ACE2 binding
alveolar epithelial cell
BA.2
BA.2.12.1
BA.4
BA.5
bind
Characteristics
COVID-19
Culture
effective
experiment
greater
hamster
Health
human ACE2
immune
immune evasion
immune resistance
Immunity
Infection
less
omicron
pathogenic
pathogenicity
provided
replicate
Reproduction number
risk
SARS-CoV-2
spike receptor-binding domain
Spread
statistical analysis
Substitution
suggested
the SARS-CoV-2
Transmissibility
[DOI] 10.1016/j.cell.2022.09.018 PMC 바로가기
[DOI] 10.1016/j.cell.2022.09.018 PMC 바로가기
Contribution of Trp63CreERT2-labeled cells to alveolar regeneration is independent of tuft cells
Article
[키워드] alveolar
alveolar epithelial cell
alveolar epithelium
alveolar regeneration
Basal cell
basal cells
Biomarkers
cause
Cell
Cell Biology
Complete
COVID-19
ectopic
epithelial
epithelial cell
function
IMPROVE
increase
independent
Infection
lineages
lung
lung parenchyma
lung regeneration
Lungs
mechanism
mice
mouse
mouse model
Notch
other organs
proliferate
promote
promoted
regenerative
regenerative medicine
regulate
significantly
stem cells
suggested
suppressed
Tamoxifen
tuft cell
tuft cells
viral infection
Wnt
[DOI] 10.7554/eLife.78217 PMC 바로가기
[DOI] 10.7554/eLife.78217 PMC 바로가기
Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19
중증 코로나바이러스 질환 치료를 위한 중간엽 줄기세포의 면역조절 측면 탐색 19
Review
[키워드] ACE-2
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
acute respiratory syndrome coronavirus-2
administration
affected
Alpha
alveolar epithelial cell
alveolar epithelial cells
angiotensin
angiotensin converting enzyme
angiotensin converting enzyme 2
anti-apoptotic
Anti-inflammatory
anti-oxidative
aspect
Asymptomatic
average
Betacoronavirus
breathlessness
cause
cellular
characterized
chemokines
chest pain
Clinical outcome
Clinical symptoms
colony-stimulating factor
coronavirus 2
COVID-19
COVID-19 patient
Critically ill
critically ill COVID-19 patients
curative
cytokine
Cytokine storm
Cytokine storms
damaged
dependent on
Deterioration
disease severity
dry cough
Effectiveness
Effects
elicited
endothelial
engage
enzyme
epithelial cells
excessive inflammation
family Coronaviridae
fatigue
Fever
fibroblast
fibroblast growth factor
functional
GCSF
genus
genus Betacoronavirus
granulocyte
granulocyte colony-stimulating factor
growth factor
Growth factors
Health
healthy
histological
IL-6
IL-7
IL-8
IL-9
immune cells
immune response
immune responses
immunomodulation
immunomodulatory
immunomodulatory capabilities
immunomodulatory capability
Incubation period
individual
infected individual
infected individuals
infiltrating immune cells
Inflammatory
Inflammatory cytokines
inflammatory protein
inhalation
Injury
Intention
interferon
interleukin
intravenous
intravenous infusion
Invasion
IP10
lung
Lungs
Macrophage
majority
MCP1
Mesenchymal stem cells
MIP1A
mitigate
monocyte
monocyte chemotactic protein-1
MSC
MSCs
multitude
myriad
Necrosis
organ
PDGFB
persistence
Platelet
platelet-derived growth factor
positioned
positive
Protein
receptor
reduce
respiratory
Respiratory droplets
RNA
SARS-CoV-2
SARS-COV-2 infection
secretion
Secretome
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus-2
sore throat
STEM
stem cell
stem cells
subunit
supportive therapy
symptomatic
therapeutic
therapy
tissue
TNF-α
translational
transmitted
Treatment
Tumor
tumor necrosis
tumor necrosis factor
tumor necrosis factor alpha
undergo
Vascular
virus
widespread
[DOI] 10.3390/cells11142175 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/cells11142175 PMC 바로가기 [Article Type] Review
SARS-CoV-2 Achieves Immune Escape by Destroying Mitochondrial Quality: Comprehensive Analysis of the Cellular Landscapes of Lung and Blood Specimens From Patients With COVID-19
SARS-CoV-2, 미토콘드리아 품질을 파괴하여 면역 탈출 달성: COVID-19 환자의 폐 및 혈액 표본의 세포 환경에 대한 종합 분석
Article
[키워드] activated
activating
alveolar
alveolar epithelial cell
alveolar epithelial cells
alveolar macrophage
Alveolar macrophages
analyzed
antiviral immunity
B cell
B cells
blocked
Blood
calcium
cell count
Comprehensive
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 patients
crossfire
cytokine
Cytokine storm
dataset
Defense
Degradation
energy metabolism
epithelial
epithelial cell
epithelial cells
escape
exacerbated
excessive inflammation
explain
expression
Gene Expression
HIF1a
Host
IFI27
immune
immune cells
Immune escape
Inflammation
inhibited
Interaction
interferon
landscape
lung tissue
Lungs
Macrophage
macrophages
manifestation
MCU
metabolic pathway
metabolism
Mitochondria
mitochondrial
mitochondrial fission
mitochondrial functions
mitochondrial quality.
pathway
patients with COVID-19
Perspective
plasma
pro-inflammatory
Regulatory T cell
regulatory T cells
released
Replication
respiratory capacity
resulting
RNA-sequencing
SARS-CoV-2
significant changes in
Single-cell RNA-sequencing
T cells
target
transformation
Tregs
type I
viral infection
[DOI] 10.3389/fimmu.2022.946731 PMC 바로가기 [Article Type] Article
[DOI] 10.3389/fimmu.2022.946731 PMC 바로가기 [Article Type] Article
Protease inhibitor Camostat Mesyalte blocks wild type SARS-CoV-2 and D614G viral entry in human engineered miniature lungs
프로테아제 억제제 Camostat Mesyalte는 인간이 조작한 소형 폐에서 야생형 SARS-CoV-2 및 D614G 바이러스 진입을 차단합니다
Article
[키워드] 3D model
alveolar
alveolar epithelial cell
AT2
block
camostat
catastrophic
cell line
cell lines
COVID-19
Culture
D614G
develop
distal
Effect
epithelial
epithelial cells
evaluate
Ex vivo
highlight
human lung
in vitro model
induce
Infection
inhibitor
involved
lentivirus
lung
lung epithelium
maturation
moderate
organ
organ culture
organoids
pandemic
Pathogenesis
pathogenesis of COVID-19
phenotype
platform
pluripotent stem cell
Prevent
progression
Protease inhibitor
provided
pseudotyped
real time
reduced
Research
respiratory tract
SARS-CoV-2
SARS-CoV-2 pandemic
significantly
the SARS-CoV-2
tissue
treat
type 2 alveolar epithelial cells
viral entry
viral infection
viral infections
virulent
while
wild type
wildtype
[DOI] 10.1016/j.biomaterials.2022.121509 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.biomaterials.2022.121509 PMC 바로가기 [Article Type] Article
SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis
SARS-CoV-2 스파이크 단백질은 미세혈관 항상성을 불안정하게 합니다.
Research Article
[키워드] ACE2
ACE2 expression
Activation
adverse effect
adverse effects
Affect
alveolar
alveolar epithelial cell
Analysis
angiotensin
angiotensin converting enzyme
angiotensin converting enzyme 2
Angiotensin II
Apoptosis
Aspirin
bind
blunt
bradykinin
calcium
Calcium signaling
caspase
cause
caused
Cell
Cell signaling
cells
Coagulopathies
complex
Concentration
contribute
contributing to
COVID-19
COVID-19 disease
decreased expression
downregulation
dysfunction
Effect
Endothelial cell
endothelial cells
Endothelial dysfunction
enzymatic activity
enzyme
epithelial
epithelial cells
event
Evidence
exposure
expressed
Factor
homeostasis
immunofluorescence microscopy
in vitro model
increased expression
indicated
infects
Inflammation
Interaction
Interference
Intervention
Krüppel
limit
lung
lung tissue
lung tissues
Lungs
mechanism
molecules
organ dysfunction
Pathogenesis
pathology
primary human cells
pro-inflammatory molecules
rationale
receptor
reduce
reduced
Respiratory function
SARS-CoV-2
SARS-CoV-2 infected individuals
SARS-COV-2 infection
Signaling
significantly
spike
Spike protein
suggested
tested
these cell
These cells
thought
thrombotic
Thrombotic events
understanding
uninfected
Vascular
viability
[DOI] 10.1128/Spectrum.00735-21 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1128/Spectrum.00735-21 PMC 바로가기 [Article Type] Research Article
The blood-gas barrier in COVID-19: an overview of the effects of SARS-CoV-2 infection on the alveolar epithelial and endothelial cells of the lung
Review
[키워드] adherens junction
alveolar epithelial cell
alveolar-capillary barrier
Blood-gas barrier
Coronavirus disease 2019
COVID-19
Endothelial cell
Extracellular matrix
severe acute respiratory syndrome coronavirus 2
tight junction
[DOI] 10.1080/21688370.2021.1937013 PMC 바로가기 [Article Type] Review
[DOI] 10.1080/21688370.2021.1937013 PMC 바로가기 [Article Type] Review
Microbiota and Its Impact on the Immune System in COVID-19—A Narrative Review
Review
[키워드] ACE2
ACE2 receptor
Affect
alveolar epithelial cell
Brain
Cell
cells
ciliary
Comorbidity
connection
COVID-19
diabetes
digestive tract
disease
enzyme
Gut
gut microbiota
host immune system
host receptor
hypertension
immune system
Impact
intestinal
intestinal enterocytes
Lungs
lungs microbiome
medications
microbe
microbiota
modulation
morbidity
narrative
number of comorbidities
obesity
organ
pandemic
pathway
Research
review
SARS-CoV-2
SARS-CoV-2 coronavirus
severity of COVID-19
shown
System
the SARS-CoV-2
therapeutic strategy
Transport
[DOI] 10.3390/jcm10194537 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/jcm10194537 PMC 바로가기 [Article Type] Review
Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue
Article
[키워드] “cytokine storm”
A1, adenosine 1 receptor
A2A, adenosine 2A receptor
A2B, adenosine 2B receptor
A3, adenosine 3 receptor
Abstract
ACE2
ACE2, angiotensin II-converting enzyme
ACh, Acetylcholine
Activation
acute respiratory syndrome
ADA, adenosine deaminase
adenosine
Ado, adenosine nucleoside
ADP, adenosine diphosphate
AEC, alveolar epithelial cell
AK, adenosine kinase
ALP, alkaline phosphatases
alveolar epithelial cell
AM, alveolar macrophages
AMP, adenosine monophosphate
APC, antigen presenting cell
ARDS, acute respiratory distress syndrome
ATP
ATP, adenosine triphosphate
binding
CCL, chemokine ligand with CC motif
CD, cluster of differentiation
CDC, Centers for Disease Control and Prevention
characterized
CLR, C-type lectin receptor
CNS, Central Nervous System
CNT, concentrated nucleoside transporters
COPD, Chronic obstructive pulmonary disease
coronavirus
coronavirus disease
cough
COVID-19
COVID-19, coronavirus disease
CT, Computed tomography
cytokine
DAMP, danger-associated molecular pattern
death
Defense
difficulty breathing
E protein, envelope protein
E-5′-NT, ecto-5′-nucleotidase
E-NPP, ectonucleotide pyrophosphatase/ phosphodiesterase
E-NTPDase, ectonucleoside triphosphate diphosphohydrolase
effective
ENT, balanced nucleoside transporters
enzyme
etiological agent
expressed
FDA, Food and Drug Administration
Fever
G-CSF, granulocyte colony-stimulating factor
GABA, γ-amino butyric acid
GVHD, Graft-versus-host disease
H1N1, influenza type A subtype H1N1 virus
HIF, hypoxia-inducible factor
ICTV, International Committee on Taxonomy of Viruses
ICU, Intensive care unit
IFN-γ, interferon gamma
IFN-I, type I interferon
IGG, immunoglobulin g
IGM, immunoglobulin m
IL-1β, interleukin 1 beta
IL, interleukin
immune
immune cells
immune system
infecting
Infection
Inflammation
Interaction
involved
IP-10, interferon gamma-induced protein 10
IPF, Idiopathic pulmonary fibrosis
Lung disease
M protein, membrane protein
MCP-1, monocyte chemotactic protein 1
mechanism
MERS-CoV, Middle East respiratory syndrome
MHC-I, major histocompatibility complex class I
MHC-II, major histocompatibility complex class II
MIP-1α, macrophage inflammatory proteins 1-alpha
modulation
N protein, nucleocapsid protein
NAc, nucleus accumbens
NET, neutrophil extracellular traps
NK, natural killer
NLRP3, NOD-, LRR- and pyrin domain-containing protein 3
organ
P1, type 1 purinergic receptor
P2, type 2 purinergic receptor
P2X7
pandemic
Pneumonia
Protein
purinergic signaling
receptor
receptors
reduce
Replication
respiratory tract
responsible
RNA, Ribonucleic acid
ROS, reactive oxygen species
RT-PCR, Reverse transcription polymerase chain reaction
S protein, spike protein
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2, severe acute respiratory syndrome coronavirus 2 virus
SARS-CoV, severe acute respiratory syndrome coronavirus
SARS, Severe acute respiratory syndrome
severity
Signaling
single-stranded RNA virus
suppress
targeting
the Coronaviridae
the cytokine storm
the disease
therapy
tissue
TNF-α, tumor necrosis factor alpha
Treatment
Trigger
viral surface
virus
WHO, World Health Organization
with COVID-19
[DOI] 10.1016/j.intimp.2021.108150 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.intimp.2021.108150 PMC 바로가기 [Article Type] Article